Apheresis Center Clinical Research 

The Apheresis Center is actively participating in a clinical study (Baylor Dendritic Cell 08-0906), which utilizes dendritic cells as novel therapeutic vaccines in cancer. 

Investigators for cellular therapy are encouraged to contact Ding Wen Wu, MD, PhD, Associate Director of Transfusion Medicine / Cellular Therapy, during the grant-writing process to seek advice on the most appropriate cellular component collection protocols.